Navigation Links
CytoGenix to Present at 2007 International DNA Vaccines Conference,in Spain

HOUSTON--(BUSINESS WIRE)--May 23, 2007 - CytoGenix, Inc. (CYGX.OB) announced today that Dr. Yin Chen, Chief Scientific Officer will present an update on preclinical animal data for DNA vaccines made using the Company's proprietary synDNA(TM) technology at the 2007 DNA Vaccines conference to be held in Malaga, Spain between May 23 and May 25.

Dr. Chen comments, "We have successfully conducted tests of synDNA(TM) based vaccines in mice, rabbits and non-human primates. The data to be presented will demonstrate the stimulation of the immune response comparing synDNA(TM) based vaccines to traditional plasmid DNA vaccines designed for the prevention of seasonal flu, HIV, smallpox and Hepatitis B. The tests indicate that the immune response triggered by synDNA(TM) vaccines is comparable to, and in some cases more effective than responses mediated by plasmid DNA. Data will also be shown demonstrating the effectiveness of a novel vaccine that protects against a highly virulent form of avian (bird) flu in animal challenge studies. These challenge experiments demonstrated that synDNA(TM) is just as effective as plasmid in mediating a protective immune response when the host is attacked by virulent viruses.

Malcolm Skolnick, CEO, states, "DNA vaccines have proven to be a potent means of providing protective immunity against viruses, bacteria and parasites in many species from fish to primates. Our animal tests demonstrate that DNA vaccines made with synDNA(TM) technology are not only effective in eliciting robust immune responses, but also provide protection against dangerous pathogens. Presentation of our data at the DNA vaccine conference is a great opportunity to showcase and discuss our work with other experts in this field including major pharmaceutical and biotech companies."

CytoGenix, Inc. is a Houston-based biopharmaceutical company that develops and markets innovative products and services based on its proprietary synDNA(TM) production and ssDNA expression technology. The company has developed a breakthrough synthetic process for large-scale production of biologically active DNA that can be made faster and cleaner than production using traditional fermentation methods and has developed a novel expression vector that enables production of therapeutic DNA inside the cell. CytoGenix currently holds 11 granted patents and about 49 international or US pending patent applications claiming methods and materials in connection with these platform technologies.

SAFE HARBOR: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology can be found on the website at www.cytogenix.com.

Contact

CytoGenix, Inc., Houston
Media Contact:
Pam Schertz, 713-789-0070


'"/>




Related medicine technology :

1. CytoGenix Announces Successful Testing of synDNA Vaccine for Avian Influenza Virus
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , January 17, 2017 - First ... MENA healthcare market expected to grow by a CAGR of ... Holding, the Qatari holding company which operates globally across a number ... achieved a number of notable successes and is well-positioned for further ... ...
(Date:1/16/2017)... -- Summary GlobalData,s new report, "North ... market data on the North America Bone Densitometers market. ... volume (in units) and average prices (USD) within market ... Ultrasound (QUS). The report also provides company shares ... segements, and global corporate-level profiles of the key market ...
(Date:1/16/2017)... , Jan. 16, 2017 Derek ... Potts Law Firm, was recently appointed Liaison Counsel in ... (JCCP) for all Xarelto cases. In this role, Potts ... parties and will actively assist the Court and Co ... with Milstein Adelman Jackson Fairchild & ...
Breaking Medicine Technology:
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... families from two offices in Tyler, has announced the latest beneficiary of their ... Wish Network, a nonprofit organization dedicated to fulfilling the dreams of terminally ill ...
(Date:1/17/2017)... ... January 17, 2017 , ... Many people make New Year’s resolutions or renew their commitment ... is making it easier for people who want to kick off 2017 with better smiles. ... patients. , These special offers include: , , A new ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... the Montclair State University’s Athletic Training Education program forged a relationship built upon ... Education Program, which is consists of both student members and certified members ...
(Date:1/16/2017)... ... 2017 , ... Recently, patients and staff from A Forever Recovery, a holistic ... in support of the annual Binder Park Zoo Halloween celebration known as the “Zoo ... of all designs coming out to enjoy games, face painting, and lots and lots ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... Gym Source, ... of a new showroom in East Hanover, New Jersey. , “We are elated to ... “The new innovative in-store concept is designed to give clients a seamless and motivating ...
Breaking Medicine News(10 mins):